Invivyd, Inc. (IVVD)

Data as of Sep 2, 2026, from SEC Form 4 filings.

XNASBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)Net insider selling (90d)Watch IVVD

See up to 3 months of IVVD. The 7-day demo opens the 1M and 3M ranges and puts IVVD on your watchlist.

Latest IVVD insider trades

Timothy Edward Lee - Officer
Open-market sale$16K
Aug 17, 2026
Timothy Edward Lee - Officer
Open-market sale

About Invivyd, Inc. (IVVD)

Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.

Headquarters: NEW HAVEN, CT
Employees: 122
Listed: 2021
Exchange: XNAS
Sector: Health Care

https://www.invivyd.com SEC filings for IVVD on EDGAR

IVVD Form 4 activity by transaction type, last 90 days

Form 4 transaction type	Transactions	Shares	Total value
Open-market sale	10	228,024	$177K
Grant or award	3	11,925,000
Option exercise	10	1,156,000

Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.

IVVD insider transactions (Form 4)

38 Form 4 filings on record, the earliest from Dec 11, 2024, newest first. Filing history page 1 of 2.

Date	Insider	Transaction	Security	Shares	Price	Value
Aug 31, 2026	Ian Sheffield - Director	Grant or award	Stock Option (Right to Buy)	100,000	$0.00	-
Aug 30, 2026	Marc Elia - Officer	Grant or award	Stock Option (Right to Buy)	10,700,000	$0.00	-
Aug 15, 2026	Timothy Edward Lee - Officer	Option exercise	Common Stock	102,000	-^{footnote F1}	-
Aug 17, 2026	Timothy Edward Lee - Officer	Open-market sale	Common Stock	22,355^{footnote F2}	$0.72^{footnote F3}	$16K
Aug 18, 2026	Timothy Edward Lee - Officer	Open-market sale	Common Stock	18,425^{footnote F2}	$0.84^{footnote F4}	$16K
Aug 15, 2026	Timothy Edward Lee - Officer	Option exercise	Restricted Stock Units	102,000	$0.00	-
Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company"). Footnote F2 (shares): The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC… Full note on SEC EDGAR
Aug 15, 2026	Julie Green - Officer	Option exercise	Common Stock	102,000	-^{footnote F1}	-
Aug 17, 2026	Julie Green - Officer	Open-market sale	Common Stock	22,355^{footnote F2}	$0.72^{footnote F3}	$16K
Aug 18, 2026	Julie Green - Officer	Open-market sale	Common Stock	18,425^{footnote F2}	$0.84^{footnote F4}	$16K
Aug 15, 2026	Julie Green - Officer	Option exercise	Restricted Stock Units	102,000	$0.00	-
Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company"). Footnote F2 (shares): The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC… Full note on SEC EDGAR
Aug 15, 2026	William E. Duke - Officer	Option exercise	Common Stock	102,000	-^{footnote F1}	-
Aug 17, 2026	William E. Duke - Officer	Open-market sale	Common Stock	22,355^{footnote F2}	$0.72^{footnote F3}	$16K
Aug 18, 2026	William E. Duke - Officer	Open-market sale	Common Stock	18,425^{footnote F2}	$0.84^{footnote F4}	$16K
Aug 15, 2026	William E. Duke - Officer	Option exercise	Restricted Stock Units	102,000	$0.00	-
Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company"). Footnote F2 (shares): The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC… Full note on SEC EDGAR
Aug 15, 2026	Jill Andersen - Officer	Option exercise	Common Stock	170,000	-^{footnote F1}	-
Aug 17, 2026	Jill Andersen - Officer	Open-market sale	Common Stock	37,256^{footnote F2}	$0.72^{footnote F3}	$27K
Aug 18, 2026	Jill Andersen - Officer	Open-market sale	Common Stock	30,706^{footnote F2}	$0.84^{footnote F4}	$26K
Aug 15, 2026	Jill Andersen - Officer	Option exercise	Restricted Stock Units	170,000	$0.00	-
Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company"). Footnote F2 (shares): The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC… Full note on SEC EDGAR
Aug 15, 2026	Robert D. Allen III - Officer	Option exercise	Common Stock	102,000	-^{footnote F1}	-
Aug 17, 2026	Robert D. Allen III - Officer	Open-market sale	Common Stock	20,679^{footnote F2}	$0.72^{footnote F3}	$15K
Aug 18, 2026	Robert D. Allen III - Officer	Open-market sale	Common Stock	17,043^{footnote F2}	$0.84^{footnote F4}	$14K
Aug 15, 2026	Robert D. Allen III - Officer	Option exercise	Restricted Stock Units	102,000	$0.00	-
Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company"). Footnote F2 (shares): The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC… Full note on SEC EDGAR
Jul 31, 2026	Michael Mina - Officer	Grant or award	Stock Option (Right to Buy)	1,125,000	$0.00	-
May 19, 2026	Ajay Royan	Grant or award	Stock Option (Right to Buy)	50,000	$0.00	-
May 19, 2026	Kevin F. McLaughlin	Grant or award	Stock Option (Right to Buy)	50,000	$0.00	-
May 19, 2026	Terrance McGuire	Grant or award	Stock Option (Right to Buy)	50,000	$0.00	-
May 19, 2026	Marc Elia	Grant or award	Stock Option (Right to Buy)	50,000	$0.00	-
May 19, 2026	Paul Bolno	Grant or award	Stock Option (Right to Buy)	32,876	$0.00	-
May 19, 2026	Tamsin Berry	Grant or award	Stock Option (Right to Buy)	50,000	$0.00	-
Feb 15, 2026	Robert D. Allen III - Officer	Option exercise	Common Stock	99,000	-^{footnote F1}	-
Feb 17, 2026	Robert D. Allen III - Officer	Open-market sale	Common Stock	18,189^{footnote F2}	$1.54^{footnote F3}	$28K
Feb 18, 2026	Robert D. Allen III - Officer	Open-market sale	Common Stock	19,392^{footnote F2}	$1.58^{footnote F4}	$31K
Feb 15, 2026	Robert D. Allen III - Officer	Option exercise	Restricted Stock Units	99,000	$0.00	-
Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company"). Footnote F2 (shares): The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC… Full note on SEC EDGAR
Feb 15, 2026	Julie Green - Officer	Option exercise	Common Stock	99,000	-^{footnote F1}	-
Feb 17, 2026	Julie Green - Officer	Open-market sale	Common Stock	19,663^{footnote F2}	$1.54^{footnote F3}	$30K
Feb 18, 2026	Julie Green - Officer	Open-market sale	Common Stock	20,964^{footnote F2}	$1.58^{footnote F4}	$33K
Feb 15, 2026	Julie Green - Officer	Option exercise	Restricted Stock Units	99,000	$0.00	-
Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company"). Footnote F2 (shares): The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC… Full note on SEC EDGAR
Feb 15, 2026	William E. Duke - Officer	Option exercise	Common Stock	99,000	-^{footnote F1}	-
Feb 17, 2026	William E. Duke - Officer	Open-market sale	Common Stock	19,663^{footnote F2}	$1.54^{footnote F3}	$30K
Feb 18, 2026	William E. Duke - Officer	Open-market sale	Common Stock	20,964^{footnote F2}	$1.58^{footnote F4}	$33K
Feb 15, 2026	William E. Duke - Officer	Option exercise	Restricted Stock Units	99,000	$0.00	-
Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company"). Footnote F2 (shares): The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC… Full note on SEC EDGAR
Feb 15, 2026	Timothy Edward Lee - Officer	Option exercise	Common Stock	99,000	-^{footnote F1}	-
Feb 17, 2026	Timothy Edward Lee - Officer	Open-market sale	Common Stock	19,663^{footnote F3}	$1.54^{footnote F4}	$30K
Feb 18, 2026	Timothy Edward Lee - Officer	Open-market sale	Common Stock	20,964^{footnote F3}	$1.58^{footnote F5}	$33K
Feb 15, 2026	Timothy Edward Lee - Officer	Option exercise	Restricted Stock Units	99,000	$0.00	-
Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company"). Footnote F3 (shares): The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S… Full note on SEC EDGAR Footnote F5 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC… Full note on SEC EDGAR
Feb 15, 2026	Jill Andersen - Officer	Option exercise	Common Stock	165,000	-^{footnote F1}	-
Feb 17, 2026	Jill Andersen - Officer	Open-market sale	Common Stock	32,771^{footnote F2}	$1.54^{footnote F3}	$50K
Feb 18, 2026	Jill Andersen - Officer	Open-market sale	Common Stock	34,939^{footnote F2}	$1.58^{footnote F4}	$55K
Feb 15, 2026	Jill Andersen - Officer	Option exercise	Restricted Stock Units	165,000	$0.00	-
Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company"). Footnote F2 (shares): The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC… Full note on SEC EDGAR
Jan 29, 2026	William E. Duke - Officer	Grant or award	Stock Option (Right to Buy)	625,000	$0.00	-
Jan 29, 2026	Julie Green - Officer	Grant or award	Stock Option (Right to Buy)	675,000	$0.00	-
Jan 29, 2026	Timothy Edward Lee - Officer	Grant or award	Stock Option (Right to Buy)	675,000	$0.00	-
Jan 29, 2026	Jill Andersen - Officer	Grant or award	Stock Option (Right to Buy)	820,000	$0.00	-
Jan 29, 2026	Robert D. Allen III - Officer	Grant or award	Stock Option (Right to Buy)	625,000	$0.00	-
Nov 19, 2025	Kevin F. McLaughlin	Open-market purchase	Common Stock	50,000^{footnote F1}	$2.50	$125K
Footnote F1 (shares): Represents shares of common stock acquired in an underwritten public offering.
Sep 22, 2025	Paul Bolno	Grant or award	Stock Option (Right to Buy)	100,000	$0.00	-
Aug 15, 2025	Timothy Edward Lee - Officer	Option exercise	Common Stock	99,000	-	-
Aug 18, 2025	Timothy Edward Lee - Officer	Open-market sale	Common Stock	20,013	$0.65	$13K
Aug 19, 2025	Timothy Edward Lee - Officer	Open-market sale	Common Stock	29,643	$0.57	$17K
Aug 15, 2025	Timothy Edward Lee - Officer	Option exercise	Restricted Stock Units	99,000	$0.00	-
Aug 15, 2025	Julie Green - Officer	Option exercise	Common Stock	99,000	-	-
Aug 18, 2025	Julie Green - Officer	Open-market sale	Common Stock	20,013	$0.65	$13K
Aug 19, 2025	Julie Green - Officer	Open-market sale	Common Stock	29,643	$0.57	$17K
Aug 15, 2025	Julie Green - Officer	Option exercise	Restricted Stock Units	99,000	$0.00	-
Aug 15, 2025	Robert D. Allen III - Officer	Option exercise	Common Stock	99,000	-	-
Aug 18, 2025	Robert D. Allen III - Officer	Open-market sale	Common Stock	18,512	$0.65	$12K
Aug 19, 2025	Robert D. Allen III - Officer	Open-market sale	Common Stock	27,420	$0.57	$16K
Aug 15, 2025	Robert D. Allen III - Officer	Option exercise	Restricted Stock Units	99,000	$0.00	-
Aug 15, 2025	Jill Andersen - Officer	Option exercise	Common Stock	165,000	-	-
Aug 18, 2025	Jill Andersen - Officer	Open-market sale	Common Stock	33,352	$0.65	$22K
Aug 19, 2025	Jill Andersen - Officer	Open-market sale	Common Stock	49,402	$0.57	$28K
Aug 15, 2025	Jill Andersen - Officer	Option exercise	Restricted Stock Units	165,000	$0.00	-

Recent IVVD Form 8-K filings

Read IVVD company news

Sep 29, 2026Item 8.01, 9.01

Read the filing on SEC EDGAR

Sep 1, 2026Item 5.02, 8.01, 9.01

Read the filing on SEC EDGAR

Aug 13, 2026Item 2.02, 9.01

Read the filing on SEC EDGAR

Jul 24, 2026Item 3.01

Recent IVVD Form 144 notices of proposed sale

An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.

Filed	Filer	Relationship	Shares	Market value	Notice
Aug 17, 2026	Andersen Jill	Officer	68,001	$49K	View on EDGAR
Aug 17, 2026	Green Julie	Officer	40,800	$29K

IVVD insider trading FAQ

What is the latest insider trade for IVVD?

Invivyd, Inc. (IVVD) had 8 insider filings in the last 90 days, with the most recent on 2026-09-02. The full record for IVVD runs to 38 Form 4 filings, the earliest from 2024-12-11. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying IVVD stock?

No insider purchases of IVVD were filed in the last 90 days. 1 purchase is on record for this company.

How many insiders are selling IVVD stock?

10 insider sales of IVVD were filed in the last 90 days, totaling $177K.

Where can I see IVVD SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects IVVD Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Sep 2, 2026 - Ian Sheffield view on EDGAR
Sep 1, 2026 - Marc Elia view on EDGAR
Aug 19, 2026 - Timothy Edward Lee view on EDGAR
Aug 19, 2026 - Julie Green view on EDGAR
Aug 19, 2026 - William E. Duke view on EDGAR
Aug 19, 2026 - Jill Andersen view on EDGAR
Aug 19, 2026 - Robert D. Allen III view on EDGAR
Aug 4, 2026 - Michael Mina view on EDGAR
May 21, 2026 - Ajay Royan view on EDGAR

Related companies with recent insider activity

Learn more

Insider selling: signal or noise?: Why most insider sales are routine, and the few patterns worth a second look.
Form 144 vs Form 4: A Form 144 announces a planned sale; the Form 4 reports it after it happens.
Insider activity in Health Care: Where IVVD's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow IVVD with a 7-day demo

IVVD on your watchlist
Every IVVD Form 4 filing on record
Up to 3 months of IVVD price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Form 4 transaction type

Transactions

Total value

Open-market sale

228,024

$177K

Grant or award

11,925,000

Option exercise

1,156,000

Date

Insider

Transaction

Security

Price

Value

Aug 31, 2026

Ian Sheffield - Director

Grant or award

Stock Option (Right to Buy)

100,000

$0.00

Aug 30, 2026

Marc Elia - Officer

Grant or award

Stock Option (Right to Buy)

10,700,000

$0.00

Aug 15, 2026

Timothy Edward Lee - Officer

Option exercise

Common Stock

102,000

-^{footnote F1}

Aug 17, 2026

Timothy Edward Lee - Officer

Open-market sale

Common Stock

22,355^{footnote F2}

$0.72^{footnote F3}

$16K

Aug 18, 2026

Timothy Edward Lee - Officer

Open-market sale

Common Stock

18,425^{footnote F2}

$0.84^{footnote F4}

$16K

Aug 15, 2026

Timothy Edward Lee - Officer

Option exercise

Restricted Stock Units

102,000

$0.00

Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
Footnote F2 (shares): The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC… Full note on SEC EDGAR

Aug 15, 2026

Julie Green - Officer

Option exercise

Common Stock

102,000

-^{footnote F1}

Aug 17, 2026

Julie Green - Officer

Open-market sale

Common Stock

22,355^{footnote F2}

$0.72^{footnote F3}

$16K

Aug 18, 2026

Julie Green - Officer

Open-market sale

Common Stock

18,425^{footnote F2}

$0.84^{footnote F4}

$16K

Aug 15, 2026

Julie Green - Officer

Option exercise

Restricted Stock Units

102,000

$0.00

Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
Footnote F2 (shares): The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC… Full note on SEC EDGAR

Aug 15, 2026

William E. Duke - Officer

Option exercise

Common Stock

102,000

-^{footnote F1}

Aug 17, 2026

William E. Duke - Officer

Open-market sale

Common Stock

22,355^{footnote F2}

$0.72^{footnote F3}

$16K

Aug 18, 2026

William E. Duke - Officer

Open-market sale

Common Stock

18,425^{footnote F2}

$0.84^{footnote F4}

$16K

Aug 15, 2026

William E. Duke - Officer

Option exercise

Restricted Stock Units

102,000

$0.00

Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
Footnote F2 (shares): The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC… Full note on SEC EDGAR

Aug 15, 2026

Jill Andersen - Officer

Option exercise

Common Stock

170,000

-^{footnote F1}

Aug 17, 2026

Jill Andersen - Officer

Open-market sale

Common Stock

37,256^{footnote F2}

$0.72^{footnote F3}

$27K

Aug 18, 2026

Jill Andersen - Officer

Open-market sale

Common Stock

30,706^{footnote F2}

$0.84^{footnote F4}

$26K

Aug 15, 2026

Jill Andersen - Officer

Option exercise

Restricted Stock Units

170,000

$0.00

Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
Footnote F2 (shares): The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC… Full note on SEC EDGAR

Aug 15, 2026

Robert D. Allen III - Officer

Option exercise

Common Stock

102,000

-^{footnote F1}

Aug 17, 2026

Robert D. Allen III - Officer

Open-market sale

Common Stock

20,679^{footnote F2}

$0.72^{footnote F3}

$15K

Aug 18, 2026

Robert D. Allen III - Officer

Open-market sale

Common Stock

17,043^{footnote F2}

$0.84^{footnote F4}

$14K

Aug 15, 2026

Robert D. Allen III - Officer

Option exercise

Restricted Stock Units

102,000

$0.00

Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
Footnote F2 (shares): The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC… Full note on SEC EDGAR

Jul 31, 2026

Michael Mina - Officer

Grant or award

Stock Option (Right to Buy)

1,125,000

$0.00

May 19, 2026

Ajay Royan

Grant or award

Stock Option (Right to Buy)

50,000

$0.00

May 19, 2026

Kevin F. McLaughlin

Grant or award

Stock Option (Right to Buy)

50,000

$0.00

May 19, 2026

Terrance McGuire

Grant or award

Stock Option (Right to Buy)

50,000

$0.00

May 19, 2026

Marc Elia

Grant or award

Stock Option (Right to Buy)

50,000

$0.00

May 19, 2026

Paul Bolno

Grant or award

Stock Option (Right to Buy)

32,876

$0.00

May 19, 2026

Tamsin Berry

Grant or award

Stock Option (Right to Buy)

50,000

$0.00

Feb 15, 2026

Robert D. Allen III - Officer

Option exercise

Common Stock

99,000

-^{footnote F1}

Feb 17, 2026

Robert D. Allen III - Officer

Open-market sale

Common Stock

18,189^{footnote F2}

$1.54^{footnote F3}

$28K

Feb 18, 2026

Robert D. Allen III - Officer

Open-market sale

Common Stock

19,392^{footnote F2}

$1.58^{footnote F4}

$31K

Feb 15, 2026

Robert D. Allen III - Officer

Option exercise

Restricted Stock Units

99,000

$0.00

Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
Footnote F2 (shares): The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC… Full note on SEC EDGAR

Feb 15, 2026

Julie Green - Officer

Option exercise

Common Stock

99,000

-^{footnote F1}

Feb 17, 2026

Julie Green - Officer

Open-market sale

Common Stock

19,663^{footnote F2}

$1.54^{footnote F3}

$30K

Feb 18, 2026

Julie Green - Officer

Open-market sale

Common Stock

20,964^{footnote F2}

$1.58^{footnote F4}

$33K

Feb 15, 2026

Julie Green - Officer

Option exercise

Restricted Stock Units

99,000

$0.00

Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
Footnote F2 (shares): The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC… Full note on SEC EDGAR

Feb 15, 2026

William E. Duke - Officer

Option exercise

Common Stock

99,000

-^{footnote F1}

Feb 17, 2026

William E. Duke - Officer

Open-market sale

Common Stock

19,663^{footnote F2}

$1.54^{footnote F3}

$30K

Feb 18, 2026

William E. Duke - Officer

Open-market sale

Common Stock

20,964^{footnote F2}

$1.58^{footnote F4}

$33K

Feb 15, 2026

William E. Duke - Officer

Option exercise

Restricted Stock Units

99,000

$0.00

Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
Footnote F2 (shares): The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC… Full note on SEC EDGAR

Feb 15, 2026

Timothy Edward Lee - Officer

Option exercise

Common Stock

99,000

-^{footnote F1}

Feb 17, 2026

Timothy Edward Lee - Officer

Open-market sale

Common Stock

19,663^{footnote F3}

$1.54^{footnote F4}

$30K

Feb 18, 2026

Timothy Edward Lee - Officer

Open-market sale

Common Stock

20,964^{footnote F3}

$1.58^{footnote F5}

$33K

Feb 15, 2026

Timothy Edward Lee - Officer

Option exercise

Restricted Stock Units

99,000

$0.00

Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
Footnote F3 (shares): The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S… Full note on SEC EDGAR
Footnote F5 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC… Full note on SEC EDGAR

Feb 15, 2026

Jill Andersen - Officer

Option exercise

Common Stock

165,000

-^{footnote F1}

Feb 17, 2026

Jill Andersen - Officer

Open-market sale

Common Stock

32,771^{footnote F2}

$1.54^{footnote F3}

$50K

Feb 18, 2026

Jill Andersen - Officer

Open-market sale

Common Stock

34,939^{footnote F2}

$1.58^{footnote F4}

$55K

Feb 15, 2026

Jill Andersen - Officer

Option exercise

Restricted Stock Units

165,000

$0.00

Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
Footnote F2 (shares): The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20… Full note on SEC EDGAR
Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC… Full note on SEC EDGAR

Jan 29, 2026

William E. Duke - Officer

Grant or award

Stock Option (Right to Buy)

625,000

$0.00

Jan 29, 2026

Julie Green - Officer

Grant or award

Stock Option (Right to Buy)

675,000

$0.00

Jan 29, 2026

Timothy Edward Lee - Officer

Grant or award

Stock Option (Right to Buy)

675,000

$0.00

Jan 29, 2026

Jill Andersen - Officer

Grant or award

Stock Option (Right to Buy)

820,000

$0.00

Jan 29, 2026

Robert D. Allen III - Officer

Grant or award

Stock Option (Right to Buy)

625,000

$0.00

Nov 19, 2025

Kevin F. McLaughlin

Open-market purchase

Common Stock

50,000^{footnote F1}

$2.50

$125K

Footnote F1 (shares): Represents shares of common stock acquired in an underwritten public offering.

Sep 22, 2025

Paul Bolno

Grant or award

Stock Option (Right to Buy)

100,000

$0.00

Aug 15, 2025

Timothy Edward Lee - Officer

Option exercise

Common Stock

99,000

Aug 18, 2025

Timothy Edward Lee - Officer

Open-market sale

Common Stock

20,013

$0.65

$13K

Aug 19, 2025

Timothy Edward Lee - Officer

Open-market sale

Common Stock

29,643

$0.57

$17K

Aug 15, 2025

Timothy Edward Lee - Officer

Option exercise

Restricted Stock Units

99,000

$0.00

Aug 15, 2025

Julie Green - Officer

Option exercise

Common Stock

99,000

Aug 18, 2025

Julie Green - Officer

Open-market sale

Common Stock

20,013

$0.65

$13K

Aug 19, 2025

Julie Green - Officer

Open-market sale

Common Stock

29,643

$0.57

$17K

Aug 15, 2025

Julie Green - Officer

Option exercise

Restricted Stock Units

99,000

$0.00

Aug 15, 2025

Robert D. Allen III - Officer

Option exercise

Common Stock

99,000

Aug 18, 2025

Robert D. Allen III - Officer

Open-market sale

Common Stock

18,512

$0.65

$12K

Aug 19, 2025

Robert D. Allen III - Officer

Open-market sale

Common Stock

27,420

$0.57

$16K

Aug 15, 2025

Robert D. Allen III - Officer

Option exercise

Restricted Stock Units

99,000

$0.00

Aug 15, 2025

Jill Andersen - Officer

Option exercise

Common Stock

165,000

Aug 18, 2025

Jill Andersen - Officer

Open-market sale

Common Stock

33,352

$0.65

$22K

Aug 19, 2025

Jill Andersen - Officer

Open-market sale

Common Stock

49,402

$0.57

$28K

Aug 15, 2025

Jill Andersen - Officer

Option exercise

Restricted Stock Units

165,000

$0.00

Filed

Filer

Relationship

Market value

Notice

Aug 17, 2026

Andersen Jill

Officer

68,001

$49K

View on EDGAR

Aug 17, 2026

Green Julie

Officer

40,800

$29K